TrialCurrent oncology (Toronto, Ont.)2022

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.

Max Seidensticker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.